GLORY HEALTH released its interim results, with a loss attributable to shareholders of 225 million yuan, an increase of 283.88% year-on-year
GLORY HEALTH released its interim results for the period ending June 30, 2025, reporting revenue of 324 million yuan, a year-on-year decrease of 67.17%; loss attributable to shareholders of 225 million yuan, a year-on-year increase of 283.88%; basic loss per share of 5.07 cents. Revenue from property development was 183 million yuan, a year-on-year decrease of 76.9%. The decrease in revenue was mainly due to a reduction in the area of completed property development delivered and sales
According to the Zhitong Finance APP, GLORY HEALTH (02329) released its interim results for the six months ending June 30, 2025, reporting revenue of RMB 324 million, a year-on-year decrease of 67.17%; the loss attributable to shareholders was RMB 225 million, a year-on-year increase of 283.88%; basic loss per share was 5.07 cents.
The announcement stated that the property development revenue for the six months ending June 30, 2025, was RMB 183 million, a decrease of 76.9% compared to the same period last year. The decrease in revenue during the reporting period was mainly due to a reduction in the area of completed property development projects and a decrease in sales
